Sandbox g56: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi- (talk | contribs) Created page with "{{PBI|Staphylococcus haemolyticus}} :* 1. '''Methicillin-susceptible strain'''<ref>{{cite book | last = Abramowicz | first = Mark | title = Handbook of antimicrobial therapy :..." |
Gerald Chi- (talk | contribs) mNo edit summary |
||
Line 1: | Line 1: | ||
{{PBI|Staphylococcus haemolyticus}} | {{PBI|Staphylococcus haemolyticus}} | ||
:* 1. '''Methicillin-susceptible strain'''<ref>{{cite book | last = Abramowicz | first = Mark | title = Handbook of antimicrobial therapy : selected articles from Treatment guidelines with updates from The medical letter | publisher = The Medical Letter | location = New Rochelle, N.Y | year = 2011 | isbn = 978-0981527826 }}</ref> | :* 1. '''Methicillin-susceptible strain'''<ref>{{cite book | last = Abramowicz | first = Mark | title = Handbook of antimicrobial therapy : selected articles from Treatment guidelines with updates from The medical letter | publisher = The Medical Letter | location = New Rochelle, N.Y | year = 2011 | isbn = 978-0981527826 }}</ref><ref>{{cite book | last = Gilbert | first = David | title = The Sanford guide to antimicrobial therapy | publisher = Antimicrobial Therapy | location = Sperryville, Va | year = 2015 | isbn = 978-1930808843 }}</ref> | ||
::* Preferred regimen (1): [[Nafcillin]] 1–2 g IV q4-6h (maximum 12 g/day) | ::* Preferred regimen (1): [[Nafcillin]] 1–2 g IV q4-6h (maximum 12 g/day) | ||
::* Preferred regimen (2): [[Oxacillin]] 1–2 g IVq4-6h (maximum 12 g/day) | ::* Preferred regimen (2): [[Oxacillin]] 1–2 g IVq4-6h (maximum 12 g/day) |
Revision as of 03:51, 27 July 2015
- Staphylococcus haemolyticus
Return to Top
-
- Preferred regimen (1): Nafcillin 1–2 g IV q4-6h (maximum 12 g/day)
- Preferred regimen (2): Oxacillin 1–2 g IVq4-6h (maximum 12 g/day)
- Preferred regimen (3): Cefazolin 0.5–2 g IV q6-8h
- Alternative regimen (1): TMP-SMX 4–5 mg/kg IV q6–12h
- Alternative regimen (2): Doxycycline 100–200 mg IV q12-24h
- 2. Methicillin-resistant, Glycopeptide-susceptible strain
- Preferred regimen: Vancomycin 15–20 mg/kg IV q8–12h
- 3. Methicillin-resistant, Glycopeptide-resistant strain
- Preferred regimen (1): Daptomycin 4–6 mg/kg IV q24h
- Preferred regimen (2): Linezolid 600 mg PO/IV q12h
- Staphylococcus saprophyticus
Return to Top
- Streptococcus anginosus
Return to Top
References
- ↑ Abramowicz, Mark (2011). Handbook of antimicrobial therapy : selected articles from Treatment guidelines with updates from The medical letter. New Rochelle, N.Y: The Medical Letter. ISBN 978-0981527826.
- ↑ Gilbert, David (2015). The Sanford guide to antimicrobial therapy. Sperryville, Va: Antimicrobial Therapy. ISBN 978-1930808843.